Generic name: nabumetone
Dosage form: tablets
Medically reviewed on April 2, 2018.
Carefully consider the potential benefits and risks of RELAFEN and other treatment options before deciding to use RELAFEN. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
After observing the response to initial therapy with RELAFEN, the dose and frequency should be adjusted to suit an individual patient’s needs.
Osteoarthritis and Rheumatoid Arthritis
The recommended starting dose is 1,000 mg taken as a single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to 2,000 mg per day. RELAFEN can be given in either a single or twice-daily dose. Dosages greater than 2,000 mg per day have not been studied. The lowest effective dose should be used for chronic treatment (see WARNINGS, Renal Effects). Patients weighing under 50 kg may be less likely to require dosages beyond 1,000 mg; therefore, after observing the response to initial therapy, the dose should be adjusted to meet individual patients’ requirements.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Relafen (nabumetone)
- Relafen Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 32 Reviews
- Drug class: Nonsteroidal anti-inflammatory drugs